Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 May;92(1-3):90-4.
doi: 10.1016/j.schres.2006.12.030. Epub 2007 Feb 23.

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial

Oliver Freudenreich  1 , David C Henderson, Jared P Walsh, Melissa A Culhane, Donald C Goff
Affiliations
Randomized Controlled Trial

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial

Oliver Freudenreich et al. Schizophr Res. 2007 May.

Abstract

Rationale: Risperidone augmentation of clozapine in refractory schizophrenia has theoretical but only inconsistent support from clinical trials.

Objectives: To examine if adding risperidone to stable yet symptomatic schizophrenia outpatients on optimized clozapine monotherapy improves psychopathology.

Methods: We conducted a double-blind placebo-controlled parallel-group trial of a fixed dose of 4 mg/day risperidone added for 6 weeks in 24 outpatients with schizophrenia.

Results: Subjects who received risperidone showed a non-significant decrease in PANSS total score. The PANSS disorganized thought subscale improved significantly (beta=-3.3079, p=0.047).

Conclusions: Our trial does not support the routine addition of risperidone to clozapine in refractory schizophrenia patients. However, much larger trials are needed to conclusively settle the question of added efficacy from this combination.

PubMed Disclaimer

Publication types